Literature DB >> 1997750

Differences in rates of cancer screening by usual source of medical care. Data from the 1987 National Health Interview Survey.

A B Bernstein1, G B Thompson, L C Harlan.   

Abstract

Data from the Cancer Control Supplement of the 1987 Health Interview Survey (NHIS), a nationally representative sample of the United States population, was used to examine rates of six screening tests for cancer. The rates of screening were compared for people who receive their usual source of medical care in an HMO or prepaid group practice versus those who receive it in the fee-for-service sector. The purpose of this article is to determine whether HMOs remain more likely to offer cancer screening examinations than the fee-for-service sector. Results indicate that for five of six screening tests examined (Pap smear, mammography, breast physical examination, digital rectal examination, and blood stool test), members of HMOs are significantly more likely to have received the test within the last 3-year period. These results hold in a multivariate analysis when many factors correlated with selection into HMOs, health status, and use of medical services are controlled for, although results are only generalizable to whites. Future research should focus on why the rates for five of the six cancer screening tests examined are higher in HMO settings, and how we can use the HMO experience to improve consensus as to the usefulness of the tests in the non-HMO physician pool, and ultimately increase rates of screening tests in the non-HMO population.

Entities:  

Mesh:

Year:  1991        PMID: 1997750

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  19 in total

1.  The relation between projected breast cancer risk, perceived cancer risk, and mammography use. Results from the National Health Interview Survey.

Authors:  C P Gross; G Filardo; H S Singh; A N Freedman; M H Farrell
Journal:  J Gen Intern Med       Date:  2005-12-22       Impact factor: 5.128

2.  The effect of area HMO market share on cancer screening.

Authors:  Laurence C Baker; Kathryn A Phillips; Jennifer S Haas; Su-Ying Liang; Dean Sonneborn
Journal:  Health Serv Res       Date:  2004-12       Impact factor: 3.402

3.  Cholesterol treatment practices of primary care physicians.

Authors:  D J Hyman; E W Maibach; J A Flora; S P Fortmann
Journal:  Public Health Rep       Date:  1992 Jul-Aug       Impact factor: 2.792

4.  Health care coverage: traditional and preventive measures and associations with chronic disease risk factors.

Authors:  N A Hagdrup; E J Simoes; R C Brownson
Journal:  J Community Health       Date:  1997-10

5.  Factors associated with women's adherence to mammography screening guidelines.

Authors:  K A Phillips; K Kerlikowske; L C Baker; S W Chang; M L Brown
Journal:  Health Serv Res       Date:  1998-04       Impact factor: 3.402

6.  Adherence of low-income women to cancer screening recommendations.

Authors:  Ann S O'Malley; Christopher B Forrest; Jeanne Mandelblatt
Journal:  J Gen Intern Med       Date:  2002-02       Impact factor: 5.128

7.  Predictors of compliance with recommended cervical cancer screening schedule: a population-based study.

Authors:  E J Simoes; C J Newschaffer; N Hagdrup; F Ali-Abarghoui; X Tao; N Mack; R C Brownson
Journal:  J Community Health       Date:  1999-04

8.  What people really know about their health insurance: a comparison of information obtained from individuals and their insurers.

Authors:  D E Nelson; B L Thompson; N J Davenport; L J Penaloza
Journal:  Am J Public Health       Date:  2000-06       Impact factor: 9.308

9.  Changes in the use of screening mammography: evidence from the 1987 and 1990 National Health Interview Surveys.

Authors:  N Breen; L Kessler
Journal:  Am J Public Health       Date:  1994-01       Impact factor: 9.308

10.  Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees.

Authors:  G F Riley; A L Potosky; J D Lubitz; M L Brown
Journal:  Am J Public Health       Date:  1994-10       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.